Intelligence Profile
Safety Profile
The current evidence on the safety profile of rosuvastatin, a statin medication often prescribed to lower cholesterol, is derived from clinical studies and reports. However, detailed safety-related data specific to rosuvastatin is sparse in the provided sources. Here's a generalized safety summary:
Known Side Effects
Common side effects of rosuvastatin may include headache, muscle pain, abdominal pain, weakness, and nausea. Serious side effects, though rare, can include liver problems and muscle disorders (e.g., rhabdomyolysis).
Contraindications
Rosuvastatin is contraindicated in patients with:
- Active liver disease.
- Known hypersensitivity to rosuvastatin or any of its components.
- Pregnancy and lactation due to potential harm to the fetus or breastfed child.
Drug Interactions
The evidence on interactions is limited. However, like other statins, rosuvastatin may interact with certain medications such as:
- Antifungal agents (e.g., itraconazole).
- Some antibiotics.
- Other cholesterol-lowering medications.
These interactions can increase the risk of muscle injury or affect the drug’s efficacy.
Populations That Should Avoid It
- Pregnant or breastfeeding women.
- Individuals with active liver disease or significant liver enzyme elevations.
- Caution is advised in elderly patients and those with severe renal impairment, as they may have an increased risk of adverse effects.
Thin Evidence
There is limited information from the provided sources about other specific populations or interactions unique to rosuvastatin. Further research and detailed pharmacovigilance studies are needed to enhance understanding.
Disclaimer
This summary is intended for informational purposes and does not substitute for professional medical advice. Always consult a healthcare provider for medical decisions.